Avadel Pharmaceuticals plc - ADR
Avadel Pharmaceuticals plc - ADR Stock, NASDAQ:AVDL
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.